220 related articles for article (PubMed ID: 18448486)
1. Sleep duration, melatonin and breast cancer among Chinese women in Singapore.
Wu AH; Wang R; Koh WP; Stanczyk FZ; Lee HP; Yu MC
Carcinogenesis; 2008 Jun; 29(6):1244-8. PubMed ID: 18448486
[TBL] [Abstract][Full Text] [Related]
2. Sleep duration, spot urinary 6-sulfatoxymelatonin levels and risk of breast cancer among Chinese women in Singapore.
Wu AH; Stanczyk FZ; Wang R; Koh WP; Yuan JM; Yu MC
Int J Cancer; 2013 Feb; 132(4):891-6. PubMed ID: 22644618
[TBL] [Abstract][Full Text] [Related]
3. Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Sieri S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
J Natl Cancer Inst; 2008 Jun; 100(12):898-905. PubMed ID: 18544743
[TBL] [Abstract][Full Text] [Related]
4. Urinary Melatonin in Relation to Postmenopausal Breast Cancer Risk According to Melatonin 1 Receptor Status.
Devore EE; Warner ET; Eliassen AH; Brown SB; Beck AH; Hankinson SE; Schernhammer ES
Cancer Epidemiol Biomarkers Prev; 2017 Mar; 26(3):413-419. PubMed ID: 28151704
[No Abstract] [Full Text] [Related]
5. Melatonin and breast cancer: a prospective study.
Travis RC; Allen DS; Fentiman IS; Key TJ
J Natl Cancer Inst; 2004 Mar; 96(6):475-82. PubMed ID: 15026473
[TBL] [Abstract][Full Text] [Related]
6. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses' Health Study cohort.
Schernhammer ES; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):74-9. PubMed ID: 19124483
[TBL] [Abstract][Full Text] [Related]
7. Sleep duration, melatonin and breast cancer in the Singapore Chinese Health Study: on null results and their interpretation.
Erren TC; Reiter RJ
Int J Cancer; 2013 Oct; 133(8):2010-1. PubMed ID: 23588800
[No Abstract] [Full Text] [Related]
8. Author's reply to: Sleep duration, melatonin and breast cancer in the Singapore Chinese Health Study: on null results and their interpretation.
Wu AH; Yu MC
Int J Cancer; 2013 Oct; 133(8):2012. PubMed ID: 23588716
[No Abstract] [Full Text] [Related]
9. Urinary levels of melatonin and risk of postmenopausal breast cancer: women's health initiative observational cohort.
Sturgeon SR; Doherty A; Reeves KW; Bigelow C; Stanczyk FZ; Ockene JK; Liu S; Manson JE; Neuhouser ML
Cancer Epidemiol Biomarkers Prev; 2014 Apr; 23(4):629-37. PubMed ID: 24510738
[TBL] [Abstract][Full Text] [Related]
10. Urinary melatonin concentration and the risk of breast cancer in Nurses' Health Study II.
Brown SB; Hankinson SE; Eliassen AH; Reeves KW; Qian J; Arcaro KF; Wegrzyn LR; Willett WC; Schernhammer ES
Am J Epidemiol; 2015 Feb; 181(3):155-62. PubMed ID: 25587174
[TBL] [Abstract][Full Text] [Related]
11. First-morning urinary melatonin and breast cancer risk in the Guernsey Study.
Wang XS; Tipper S; Appleby PN; Allen NE; Key TJ; Travis RC
Am J Epidemiol; 2014 Mar; 179(5):584-93. PubMed ID: 24418683
[TBL] [Abstract][Full Text] [Related]
12. Urinary Melatonin in Relation to Breast Cancer Risk: Nested Case-Control Analysis in the DOM Study and Meta-analysis of Prospective Studies.
Wong ATY; Fensom GK; Key TJ; Onland-Moret NC; Tong TYN; Travis RC
Cancer Epidemiol Biomarkers Prev; 2021 Jan; 30(1):97-103. PubMed ID: 33144281
[TBL] [Abstract][Full Text] [Related]
13. Sleep duration, nightshift work, and the timing of meals and urinary levels of 8-isoprostane and 6-sulfatoxymelatonin in Japanese women.
Nagata C; Tamura T; Wada K; Konishi K; Goto Y; Nagao Y; Ishihara K; Yamamoto S
Chronobiol Int; 2017; 34(9):1187-1196. PubMed ID: 28933565
[TBL] [Abstract][Full Text] [Related]
14. Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort.
Schernhammer ES; Berrino F; Krogh V; Secreto G; Micheli A; Venturelli E; Grioni S; Sempos CT; Cavalleri A; Schünemann HJ; Strano S; Muti P
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):729-37. PubMed ID: 20200429
[TBL] [Abstract][Full Text] [Related]
15. Urinary melatonin levels and breast cancer risk.
Schernhammer ES; Hankinson SE
J Natl Cancer Inst; 2005 Jul; 97(14):1084-7. PubMed ID: 16030307
[TBL] [Abstract][Full Text] [Related]
16. Urinary 6-sulfatoxymelatonin and mammographic density in Japanese women.
Nagata C; Matsubara T; Hara T; Fujita H; Nagao Y; Yamamoto S; Shibuya C; Kashiki Y; Shimizu H
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2509-12. PubMed ID: 18006946
[TBL] [Abstract][Full Text] [Related]
17. Association of urinary levels of 6-sulfatoxymelatonin (aMT6s) with prevalent and incident hypertension.
Pérez-Caraballo AM; Ma Y; Ockene JK; Reeves KW; Balasubramanian R; Stanczyk FZ; Allison MA; Chen C; Wang L; Manson JE; Sturgeon SR
Chronobiol Int; 2018 Aug; 35(8):1115-1121. PubMed ID: 29750588
[TBL] [Abstract][Full Text] [Related]
18. Disruption of sleep, sleep-wake activity rhythm, and nocturnal melatonin production in breast cancer patients undergoing adjuvant chemotherapy: prospective cohort study.
Li W; Kwok CC; Chan DC; Ho AW; Ho CS; Zhang J; Wing YK; Wang F; Tse LA
Sleep Med; 2019 Mar; 55():14-21. PubMed ID: 30743205
[TBL] [Abstract][Full Text] [Related]
19. Sleep duration and breast cancer: a prospective cohort study.
Verkasalo PK; Lillberg K; Stevens RG; Hublin C; Partinen M; Koskenvuo M; Kaprio J
Cancer Res; 2005 Oct; 65(20):9595-600. PubMed ID: 16230426
[TBL] [Abstract][Full Text] [Related]
20. No effect of exercise on urinary 6-sulfatoxymelatonin and catecholamines in young women participating in a 16-week randomized controlled trial.
Arikawa AY; Thomas W; Patel SR; Kurzer MS
Cancer Epidemiol Biomarkers Prev; 2013 Sep; 22(9):1634-6. PubMed ID: 23861293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
